PRF Technologies Ltd. PRFX
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $17,000 · Filed Mar 26, 2026
PRF Technologies Ltd. (PRFX) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $17,000 and a net loss of $5.0 million. Free cash flow was -$4.0 million. As of Dec 31, 2025 it held $10.8 million in cash and investments and $21,000 in total debt.
Revenue
$17,000
Net income
$-5.02M
+65.6% vs prior year
Operating cash flow
$-3.96M
+68.7% vs prior year
Free cash flow
$-3.96M
+68.7% vs prior year
EPS
$-7.47
+92.9% vs prior year
Dividend per share
None
Shares outstanding
830,613
-43.5% vs prior year
Net cash
$10.75M
FY 2025
Operating margin
-30129.4%
FY 2025
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRFX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1801834
- Former names
- PAINREFORM LTD. (until Jan 20, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $17,000 | — | — | — | — |
| Operating income | -$5.1M | -$14.7M | -$9.6M | -$8.9M | -$7.2M |
| Net income | -$5.0M | -$14.6M | -$9.3M | -$8.8M | -$7.2M |
| Diluted EPS | -$7.47 | -$105.52 | -$122.94 | -$63.46 | — |
| Operating cash flow | -$4.0M | -$12.6M | -$6.7M | -$6.5M | -$6.6M |
| Free cash flow | -$4.0M | -$12.6M | -$6.7M | -$6.5M | -$6.6M |
| Total assets | $12.0M | $4.5M | $9.9M | $12.3M | $19.1M |
| Total liabilities | $2.7M | $2.7M | $2.7M | $1.3M | $991,000 |
| Stockholders' equity | $8.5M | $1.8M | $7.2M | $11.0M | $18.1M |
| Cash and investments | $10.8M | $4.4M | $8.2M | $10.2M | $16.5M |
| Total debt | $21,000 | $78,000 | $86,000 | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Oct 23, 2026 | Oct 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 28, 2026 | Sep 28, 2026 |
| 6-K | Current report (foreign issuer) | Sep 16, 2026 | Sep 16, 2026 |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| 6-K | Current report (foreign issuer) | Sep 3, 2026 | Jun 30, 2026 |
All 262 PRF Technologies Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.